4 December 2008: Notice of extraordinary general meeting is enclosed. The general meeting is scheduled for December 19, 10:00 am, and will take place at the Company`s office, Frysjaveien 40, Oslo.

In the meeting, will it be among others, proposed to increase the Company`s share capital with minimum NOK 5,000,000 and maximum NOK 12,023,451 by issuance of minimum 50,000,000 and maximum 120,234,510 shares with nominal value NOK 0.10 per share. The registered shareholders as of December 19 will have a pre-empty right to subscribe for and be allotted new shares.

The subscription price for the new shares is proposed to NOK 0.50. Furthermore, it is proposed that there shall be issued warrants to the participants and underwriters in the rights issue and to employees who accepts reduction in their wages.

The minimum of 50,000,000 new shares have been underwritten by an underwriting syndicate established by the Company. The syndicate consists of both existing NorDiag shareholders and new investors.

On the agenda, there will also be election for the board, where the nomination committee has proposed Robert V. Ahlgren as new chairman of the board of directors, and incentive program for employees in the Company.

Complete notice is attached.

Contact: CEO Mårten Wigstøl Phone. +47 911 65775

About NorDiag:
NorDiag is a biotechnology company developing, manufacturing and marketing automated solutions, instruments and tests, for diagnostic of infectious diseases and cancer. The Company`s core competence is isolation of bacterial and human DNA from difficult clinical samples, and the Company has established a solid market share in the Scandinavian market for sexually transmitted infections. The company has similar applications for Tuberculosis and MRSA. An application for respiratory pathogens is under development. NorDiag is also developing a test that shall contribute to early diagnosis of colorectal cancer. NorDiag was founded in 2003 and has its headquarters in Oslo - Norway. The Company has offices and laboratories in Bergen - Norway, Stockholm - Sweden and West Chester (PA) - USA. The group has 39 employees. NorDiag is listed on Oslo Stock Exchange with the ticker NORD. For further information - www.nordiag.com.

Read the complete notice here

Read the notice in Norwegian here